Literature DB >> 6147619

Oral acyclovir for herpes zoster.

R Finn, M A Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6147619     DOI： 10.1016/s0140-6736(84)90785-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Severe herpes zoster infection in the United Kingdom: experience in a regional infectious disease unit.

Authors:  P Bannister; B Crosse
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

2.  Herpes zoster and its neurological complications.

Authors:  C M Chang; E Woo; Y L Yu; C Y Huang; D Chin
Journal:  Postgrad Med J       Date:  1987-02       Impact factor: 2.401

Review 3.  Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  J J O'Brien; D M Campoli-Richards
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

4.  Pharmacological and non-pharmacological strategies for preventing postherpetic neuralgia: a systematic review and network meta-analysis.

Authors:  Junhyeok Kim; Min Kyoung Kim; Geun Joo Choi; Hwa Yong Shin; Beom Gyu Kim; Hyun Kang
Journal:  Korean J Pain       Date:  2021-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.